BAM
GWPH

Belpointe Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Belpointe Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,092
Closed -$237K – 1193
2021
Q1 		$237K Sell
1,092
-670
-38% -$126K 0.02% 686
2020
Q4 		$203K Buy
+1,762
New +$197K 0.02% 688
2020
Q3 		– Sell
-1,848
Closed -$227K – 831
2020
Q2 		$227K Buy
+1,848
New +$210K 0.03% 485
2020
Q1 		– Sell
-1,294
Closed -$135K – 830
2019
Q4 		$135K Sell
1,294
-704
-35% -$78.9K 0.02% 669
2019
Q3 		$230K Sell
1,998
-76
-4% -$11.5K 0.04% 442
2019
Q2 		$358K Buy
2,074
+204
+11% +$35.3K 0.07% 298
2019
Q1 		$315K Buy
1,870
+407
+28% +$60.6K 0.06% 239
2018
Q4 		$142K Buy
1,463
+85
+6% +$11.2K 0.04% 408
2018
Q3 		$237K Buy
+1,378
New +$199K 0.04% 411

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Belpointe Asset Management's GWPH Position: Q2 2021 in Review

Belpointe Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,092 shares — an estimated $237K sold.

Belpointe Asset Management first reported a position in GWPH in Q3 2018 and held it in 9 quarters. The position peaked at $358K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Belpointe Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Belpointe Asset Management sold 1,092 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $237K.
  • Belpointe Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 9 quarters.
  • Belpointe Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $358K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Belpointe Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.